Action by the FDA
HHS;PHS;FDA;CFSAN;OFP;DCP;MSB 200 C' Street, S.W. Washington, DC 20204 M-I-97- 3 February 28, 1997 To: All Regional Food and Drug Directors ATT: Regional Milk Specialists FROM: Milk Safety Branch (HFS-626) SUBJECT: Colloidal Silver Please find enclosed an FDA UPDATE which explains the U.S. Food and Drug Administration position in regards to colloidal silver. The use of colloidal silver-containing products constitutes a potentially serious public health concern because of the possibility of residues in milk or meat. The consumption of silver by humans may result in argyria - a permanent ashen-gray or blue discoloration of the skin, conjunctiva, and internal organs. Colloidal silver-containing products have never been approved by the FDA for treatment of animal disease in any animal species. The "new" item 15r of the PMO, Administrative Procedures #6 requires that "Unapproved and/or improperly labeled medicinals/drugs are not used to treat dairy animals and are not stored in the milkhouse, milking barn, stable or parlor." Copies of this memorandum are enclosed for distribution to District Milk Specialists, State Milk Regulatory Agencies, State Veterinary Boards/Associations, State Laboratory Evaluation Officers and State Milk Rating Officers in your region. This memorandum is also available on the FDA Prime Connection computer bulletin board system (now accessible through the World Wide Web, Center for Food Safety and Applied Nutrition's home page, hhtp//VM.CFSAN.FDA.GOV). This memorandum should be widely distributed to representatives of the milk industry and other interested parties. Joseph M. Smucker Chief, Milk Safety Branch Center for Food Safety and Applied Nutrition HFS-626 200 "C" Street, SW Washington, DC 20204